Insights on the Mental Illness Drugs Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027
The global mental illness drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to accelerate the growth of the market include the rise in the prevalence of mental health disorders, such as schizophrenia and bipolar disorder among the population. According to the Anxiety and Depression Association of America, Anxiety disorders are the most common mental illness in the US, affecting 40 million adults in the US aged 18 and older, or 18.1% of the population every year. Nearly one-half of those diagnosed with depression are also diagnosed with an anxiety disorder. The World Health Organization (WHO) has recommended mental health action plan to promote mental health and prevent mental disorders in the member states. Moreover, according to the key facts published by the WHO, an estimated 300 million people are affected by depression, and 60 million people are affected by bipolar disorder, globally.
To Request a Sample of our Report on Mental Illness
Drugs Market: https://www.omrglobal.com/request-sample/mental-illness-drugs-market
Anxiety disorders are the most common psychiatric illnesses affecting
children and adults. It is evaluated that 44 million American grown-ups
experience the ill effects of uneasiness. Merely, about one-third of those
suffering from an anxiety disorder receive treatment, even though the disorders
are highly treatable. Therefore, the rising prevalence of mental disorders is
contributing to the growth of the market. Schizophrenia is a serious mental
disorder and is affecting a large number of people across the globe. The
disease is mainly characterized by distortions in thinking, emotions, and sense
of self and behavior. World Health Organization has stated that around 23
million people across the globe are affected by this disorder among which 12
million are male and 9 million are females. National Institute of Mental Health
has stated that the prevalence of Schizophrenia and related symptoms is around
0.25% and 0.64% and this is increasing rapidly. This rise in the prevalence of
the disease is contributing to market growth during the forecast period.
Market Coverage
• The market number
available for – 2020-2027
• Base year- 2020
• Forecast period-
2021-2027
Segment Covered-
·
By Product Type
·
By Application
Regions covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
·
Competitive Landscape: Eli Lily and Company, AstraZeneca plc,
GlaxoSmithKline plc, and Pfizer Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Mental Illness Drugs Market is Available @ https://www.omrglobal.com/industry-reports/mental-illness-drugs-market
Global Mental Illness Drugs Market Report by Segment
By Product Type
·
Antipsychotics
·
Antidepressants
·
Anxiolytics
·
Anti-Seizure
·
Stimulants
By Application
• Hospitals
• Clinics
• Drug Stores
Global Mental Illness Drugs Market by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid data
sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment